Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield TX Prior Auth Codes | OpenP…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBlue Cross Blue Shield - TexasPolicy N/A

    2024 Commercial Prior Authorization Codes for ASO (partial list)

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Texas policy alerts

    Know when Blue Cross Blue Shield - Texas releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    List of CPT and HCPCS codes and service categories for which prior authorization may be required for Blue Cross Blue Shield of Texas commercial plans; identifies managed-by entity (Carelon) and provides initiation methods for authorization requests. Affects providers seeking prior authorization for listed services.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    Policy2024 Commercial Prior Authorization Codes for ASO (partial list)
    Policy CodePolicy N/A
    Change TypeNo material changes in this revision
    Effective DateJan 1, 2024
    Next Review DateN/A
    Key ActionObtain prior authorization via Availity Authorization & Referrals, Blue Approvr, the member ID card number, or Carelon (1-866-455-8415) for codes managed by Carelon.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Dozenscodes listed in this partial document
    Carelonmanaged-by for many services
    1/1/2024effective date
    Multiple sectionsclinical areas
    Partial listdocument scope

    Prior Authorization Coverage Criteria

    inv-01: Prior authorization requirement summary

    Prior authorization may be required for the CPT/HCPCS codes and service categories listed below; many entries designate Carelon as the managing reviewer and some codes include effective-date annotations.

    Prior authorization may be required for listed CPT/HCPCS codes and service categories as of the effective date noted in this document (Effective 1/1/2024).
    Many listed codes indicate a managing reviewer/vendor; Carelon is identified for numerous entries and should be contacted for authorization processing when noted.

    inv-02: Prior authorization list (partial)

    Procedures listed below require prior authorization through the indicated reviewer/vendor.

    Prior authorization required for listed CPT/HCPCS codes; contact the indicated reviewer/vendor (e.g., Carelon) for authorization.

    Examples (partial)

    • 72159 — Magnetic Resonance Angiography Spinal Canal and Contents; Managed by Carelon (authorization required).
    • 74170/74174/74175 — CT/CTA abdomen/pelvis entries shown with Carelon as manager (authorization required).
    • 76376/76377 — 3D rendering codes listed with Carelon routing (authorization required).

    inv-03: Prior authorization and routing rules (code list)

    Listed CPT and temporary T-codes require prior authorization; many are routed to Carelon. Specific echocardiography and Doppler codes are flagged for ASO list inclusion effective 01/01/2024.

    Prior authorization required for advanced imaging, PET/SPECT/CT, nuclear cardiology and related CPT/T-codes listed in this section.
    Carelon is the indicated review vendor/manager for many of the imaging and cardiology codes.

    Echocardiography / Doppler ASO flags

    • 93303–93308, 93312–93317 — transthoracic and transesophageal echocardiography entries routed to Carelon and noted 'Add to ASO List effective 1/1/2024'.
    • 93320, 93321, 93325, 93350–93352 — Doppler and stress echocardiography codes routed to Carelon and flagged 'Add to ASO List effective 1/1/2024'.

    inv-04: Prior authorization code list (partial)

    This excerpt enumerates selected procedure and HCPCS/T-code examples that require prior authorization and often designates the reviewer/manager.

    0042T, 0633T, 0634T, 0635T, 0636T, 0637T, 0638T, 0648T — CT/MRI/T-code entries listed with Carelon routing (prior authorization required).
    78811, 78812, 78813, 78814, 78815, 78816 — PET imaging codes shown with Carelon as manager (authorization required).

    inv-05: Prior authorization requirement (partial)

    Prior authorization is required for the molecular genetic CPT codes in this segment; Carelon is indicated as the reviewer for most entries.

    Prior authorization required for listed molecular genetic CPT codes (gene-specific tests and panels).

    Selected gene-specific examples

    • 81174–81180 series (gene analyses for neurologic/expansion disorders) — Carelon routing indicated (authorization required).
    • 81274–81287 series (Huntingtin, KRAS, JAK2 etc.) — Carelon routing indicated (authorization required).
    • 81360–81364 (hemoglobin gene analyses) — managed by Carelon (authorization required).

    inv-06: Prior authorization list - molecular genetic testing (excerpt)

    Listed molecular genetic CPT codes and molecular pathology procedure levels require prior authorization.

    Prior authorization required for molecular genetic CPTs including representative entries such as 81274–81276 and 81360–81364.
    Molecular pathology procedure levels (81400–81410 range) are listed and require prior authorization; many entries specify Carelon as the reviewer.

    Examples (partial)

    • 81400 — Molecular pathology procedure level example (identification of single germline variant) — prior authorization indicated.
    • 81401–81407, 81410 — molecular pathology procedure levels with examples; Carelon referenced for review.

    inv-07: Prior authorization requirement for molecular genetic and genomic testing

    The listed CPT codes for molecular genetic and molecular pathology testing require prior authorization and are routed to Carelon; certain codes include panel composition or analytic requirements.

    Prior authorization required for molecular pathology and genomic sequencing CPTs (examples include 81412–81419, 81422, 81425–81427).
    Some code entries specify required panel composition or minimum gene counts (e.g., 81412 — Tay-Sachs related panel must include sequencing of at least 9 genes).

    Re-evaluation / exome re-analysis

    • 81418, 81419, 81422 — codes for exome re-evaluation or re-analysis require prior authorization and are routed to Carelon.
    • 81415–81416 — exome sequencing (and comparator exomes) listed with Carelon as manager; prior authorization required.

    inv-08: Prior authorization coverage criteria and panel composition notes

    Prior authorization is required for the molecular genetic/genomic procedure codes listed; per-code panel composition, minimum gene counts, and analytic notes are provided where specified.

    Prior authorization required for the molecular/genomic CPT codes in this section; many entries specify panel requirements and analysis types.

    Panel composition examples

    • 81431 — Hearing loss panels must include sequencing of ≥60 genes and include copy-number analysis for STRC and DFNB1 (prior authorization required).
    • 81432 — Hereditary breast cancer panel must include ≥10 genes including BRCA1, BRCA2, and other listed genes (prior authorization required).
    • 81441 — Nuclear-encoded mitochondrial genomic panel must include ≥100 genes; inherited bone marrow failure syndromes panel must include ≥30 genes (prior authorization required).

    inv-09: Prior authorization listing and mapping

    Procedure and laboratory codes in this section require prior authorization; many map to Carelon for authorization handling and include clinical context notes.

    Prior authorization required for numerous molecular genetic and related procedure codes; Carelon is associated with many entries as the authorization manager.

    Examples (partial)

    • 81554 — transbronchial biopsy diagnostic algorithm reported as categorical result — Carelon routing indicated (authorization required).
    • 0071U, OO69U and other U-codes for gene-specific or expression profiling tests listed with Carelon routing — prior authorization required.

    inv-10: Prior authorization required tests (U-codes)

    Prior authorization is required for the following U-code molecular genetic tests and panels; many entries designate Carelon as reviewer.

    Prior authorization required for selected U-code molecular/genetic tests and panels (examples include 0131U–0135U, 0211U–0213U, 0244U–0253U).

    Selected U-code examples

    • 0131U / 0132U / 0134U — targeted mRNA sequence panels for hereditary cancer indications; listed as 'List Separately In Addition To Code For Primary Procedure' and routed to Carelon.
    • 0211U / 0212U / 0213U — cytogenomic and whole-genome analysis U-codes listed with Carelon routing (authorization required).
    • 0244U / 0250U / 0253U — oncology and reproductive medicine U-codes with Carelon indicated (authorization required).

    inv-11: Authorization criteria — enumerated tests

    Listed molecular/genetic U-codes and high-complexity tests require prior authorization and, where indicated, are managed by Carelon.

    Prior authorization required for the enumerated molecular/genetic U-codes and high-complexity assays; Carelon is noted as the reviewer for many items.

    Representative high-complexity test examples

    • 0274U–0278U — hematology/genetic platelet and thrombocytopenia panels (Carelon routing; prior authorization required).
    • 0341U / 0343U / 0368U — MRD and pan-tumor whole-genome/transcriptome tests listed with Carelon routing and some entries marked 'Add effective 01/01/2024' (prior authorization required).

    inv-12: Prior authorization requirement (listing)

    Codes and test descriptions requiring prior authorization through Carelon are listed; some codes include effective dates for addition.

    Carelon is listed as the authorization entity for multiple U-code molecular genetic tests (examples include 0368U, 0378U, 0379U).

    Effective-date flag examples

    • 0368U, 0378U — 'Add effective 01/01/2024' annotated for these MRD/genomic panel codes (prior authorization required from that date).
    • 0405U, 0428U, 0449U — other U-codes shown with future 'Add effective' dates in the document; providers should note effective dates when requesting authorization.

    inv-13: Prior authorization requirement for listed procedures

    Musculoskeletal, joint and spine procedure codes listed here require prior authorization through the designated reviewer (Carelon); many codes include effective-date annotations.

    Prior authorization required for the musculoskeletal, joint and spine CPTs listed in this section; Carelon is the designated reviewer for many entries.

    Selected musculoskeletal/spine examples

    • 22208–22220 series — spinal osteotomy and related procedures listed with Carelon routing (authorization required).
    • 23455–23474 series — shoulder capsulorrhaphy and arthroplasty codes listed with Carelon routing (authorization required).
    • 23700 — manipulation under anesthesia, shoulder joint — annotated 'Add effective 01/01/2024' and listed as requiring prior authorization via Carelon.

    inv-14: Prior authorization list (musculoskeletal/joint and spine)

    Procedures in the musculoskeletal/joint and spine categories require prior authorization through Carelon; some entries indicate they were added effective 01/01/2024.

    Prior authorization required for listed arthroscopy, arthroplasty, revision and spine surgery CPTs; many entries are routed to Carelon for authorization.

    Arthroscopy / hip examples

    • 29860–29916 series — hip and knee arthroscopy codes listed with Carelon routing; several annotated 'Add effective 01/01/2024'.
    • 29887–29892 — osteochondritis and related arthroscopy procedures listed with Carelon routing and effective-date notes (authorization required).

    inv-15: Prior authorization criteria for listed CPTs

    Listed spine and related CPTs require prior authorization with Carelon as the designated reviewer.

    Provider must obtain prior authorization through Carelon for the listed CPTs covering spine decompression, laminectomy, discectomy, corpectomy and related procedures.

    Selected spine procedure examples

    • 62280–62327 series — spine injection and neurolytic injection CPTs require prior authorization via Carelon.
    • 63001–63057 series — laminectomy/laminotomy and decompression CPTs listed with Carelon routing (authorization required).
    • 63101–63103, 63250–63285 — vertebral corpectomy and vertebral resection entries routed to Carelon (prior authorization required).

    Representative Codes and Coding Notes

    Advanced Imaging/Radiology examplesCPTCovered
    70336Magnetic Resonance Imaging Temporomandibular Joint(s)
    70450Computed Tomography Head or Brain; Without Contrast
    70460CT Head or Brain; With Contrast
    Molecular genetic lab testing examplesHCPCSCovered
    0204UOncology (Thyroid) mRNA gene expression analysis of 593 genes; FNA; reported detected/not detected
    0452UOncology (bladder) methylated PENK DNA detection by LTE-qMSP, urine
    Selected advanced imaging CPT/HCPCS codesCPTCovered
    72159Magnetic Resonance Angiography Spinal Canal And Contents With Or Without Contrast Material(s)
    72191Computed Tomographic Angiography Pelvis With Contrast Material(s) Including Noncontrast Images If Performed And Image Postprocessing
    73200Computed Tomography Upper Extremity; Without Contrast Material
    Additional imaging and nuclear medicine codesCPTCovered
    763763D Rendering With Interpretation And Reporting ... Not Requiring Image Postprocessing On An Independent Workstation
    77046Magnetic Resonance Imaging Breast Without Contrast Material; Unilateral
    78012Thyroid Uptake Single Or Multiple Quantitative Measurement(s)
    nuclear cardiology/perfusionCPTCovered
    78430Myocardial Imaging PET Perfusion Study; single study at rest or stress
    78431Myocardial Imaging PET Perfusion Study; multiple studies at rest and stress
    78451Myocardial Perfusion Imaging Tomographic (SPECT); single study at rest or stress
    PET/CT, CT, T-codesmixedCovered
    78811Positron Emission Tomography (PET) Imaging; Limited Area
    78812Positron Emission Tomography (PET) Imaging
    0042TCerebral perfusion analysis using CT with post-processing
    0633TCT Breast including 3D rendering; unilateral without contrast
    Advanced imaging / cardiology codesCPT | HCPCS | mixedCovered
    93351Echocardiography code listed under prior authorization
    93352Use of echocardiographic contrast agent during stress echocardiography; listed as prior auth
    0042TCerebral perfusion analysis using CT with contrast; prior auth
    0633TComputed tomography breast, unilateral without contrast; prior auth
    0648TQuantitative MRI for tissue composition; prior auth
    Molecular genetic testing codesCPT | mixedCovered
    81120IDH1 molecular genetic test (listed under molecular genetic lab testing requiring prior authorization)
    81162BRCA1/BRCA2 full sequence and duplication/deletion analysis (requires prior auth)
    81165BRCA full duplication/deletion analysis (requires prior auth)
    Example gene-specific molecular genetic CPT codes requiring prior authorization (partial list)CPTCovered
    81174Spinal And Bulbar Muscular Atrophy (Kennedy Disease) gene analysis; known familial variant
    81212BRCA1/BRCA2 gene analysis; specific variants
    81223CFTR gene analysis; full gene sequence
    81271HTT (Huntingtin) gene analysis; evaluation to detect expanded alleles
    81244FMR1 (Fragile X) gene analysis; characterization of alleles including methylation
    81270JAK2 gene analysis; V617F variant
    Selected CPT codes requiring prior authorization (excerpt)CPTCovered
    81274Htt (Huntingtin) gene analysis; characterization of alleles (expanded size)
    81275Molecular genetic lab testing (example entry)
    81361Hbb (Hemoglobin Subunit Beta) gene analysis; common variants (eg Hbs Hbc Hbe)
    81400Molecular pathology procedure level (identification of single germline variant by techniques such as restriction enzyme digestion or melt curve analysis) with multiple gene examples
    Molecular pathology procedure levelsCPTCovered
    81401Molecular Pathology Procedure Level 2 (2-10 targets; examples and genes listed)
    81403Molecular Pathology Procedure Level 4 (single exon or >10 amplicons; examples and genes listed)
    81404Molecular Pathology Procedure Level 5 (analysis of 2-5 exons; examples and genes listed)
    81405Molecular Pathology Procedure Level 6 (6-10 exons or regionally targeted cytogenomic analysis)
    81406Molecular Pathology Procedure Level 7 (11-25 exons; examples and genes listed)
    81407Molecular Pathology Procedure Level 8 (26-50 exons or multi-gene platforms)
    81410Molecular Pathology Procedure Level 9 (>50 exons in single gene)
    Exome/genome sequencing codesCPTCovered
    81415Exome sequencing (primary)
    81416Exome sequencing with comparator (e.g., parents)
    81418Exome re-evaluation
    81419Exome re-evaluation - epilepsy panel example gene list
    81425Genome sequencing
    81426Genome sequencing with comparator
    81427Genome re-evaluation
    selected molecular/genomic codes with panel requirementsCPTCovered
    81418Exome; re-evaluation or drug metabolism panel with at least 6 genes including CYP2C19 and CYP2D6 with duplication/deletion analysis
    81419Exome; re-evaluation or epilepsy genomic panel including a long list of epilepsy genes (e.g., SCN1A, SCN8A, etc.)
    81431Hearing loss panel—sequencing of at least 60 genes and copy number analysis for STRC and DFNB1 deletions
    81432Hearing loss panel (60+ genes) and hereditary breast cancer panel (≥10 genes including BRCA1/2, TP53, etc.)
    81441Nuclear-encoded mitochondrial genomic panel (≥100 genes) and inherited bone marrow failure syndromes panel (≥30 genes)
    81455Solid organ or hematolymphoid neoplasm panel with 51+ genes; interrogation for sequence and copy number variants
    81518Oncology (breast) mRNA gene expression profiling by RT-PCR of 11 genes
    examples of molecular/genetic procedure codes requiring prior authorizationmixedCovered
    81554Utilizing transbronchial biopsies diagnostic algorithm reported as categorical result (e.g., UIP)
    81595mRNA gene expression profiling by RT-qPCR (cardiology heart transplant) reported as rejection risk score
    OO01URed blood cell antigen typing DNA — human erythrocyte antigen gene analysis
    0048UDNA targeted sequencing of protein-coding exons of 468 cancer-associated genes
    0071UCYP2D6 full gene sequence analysis
    0118UDonor-derived cell-free DNA quantification by whole genome NGS
    Selected U-code molecular/genetic tests listedmixedCovered
    0131UTargeted mRNA sequence analysis panel (13 genes) - hereditary endometrial cancer
    0132UTargeted mRNA sequence analysis panel (17 genes) - hereditary ovarian cancer–related disorders
    0211UCytogenomic constitutional (genome-wide) analysis / oncology pan-tumor DNA and RNA by NGS
    0244UOncology (solid organ) DNA comprehensive genomic profiling (257 genes)
    0253UEndometrial receptivity analysis - RNA gene expression profile (238 genes)
    0274UHematology (genetic platelet disorders) genomic sequence analysis (62 genes)
    Representative high-complexity molecular/genomic testsCPTCovered
    0297UOncology (Pan Tumor) Whole Genome Sequencing of paired malignant and normal DNA
    0298UOncology (Pan Tumor) Whole Transcriptome Sequencing of paired malignant and normal RNA
    0335UTargeted genomic sequence analysis / whole genome sequence analysis for rare diseases
    0341UAnalysis of minimal residual disease (MRD) from plasma personalized to each patient
    0368UGenomic sequence analysis with MRD quantification; colorectal cancer circulating cfDNA risk score
    U-code molecular genetic tests (sample)HCPCSCovered
    0368UMolecular Genetic Lab Testing — Oncology (Hematolymphoid Neoplasm) Genomic Sequence Analysis ... minimal residual disease (MRD); also referenced as Carelon
    0378UMolecular Genetic Lab Testing — Rfc1 repeat expansion variant analysis by PCR
    0379UMolecular Genetic Lab Testing — Targeted genomic sequence analysis panel (solid organ neoplasm, 523 DNA genes / 55 RNA genes)
    Musculoskeletal / spine CPT codes (sample)CPTCovered
    20930Allograft morselized or placement of osteopromotive material for spine surgery (list separately)
    22206Osteotomy of spine posterior or posterolateral approach; thoracic
    22510Percutaneous vertebroplasty (bone biopsy included when performed)
    Select spine and musculoskeletal CPT codes requiring authorization (excerpt)CPTCovered
    22208Osteotomy Of Spine Posterior Or Posterolateral Approach 1 vertebral segment; each additional segment listed separately
    22510Percutaneous vertebroplasty vertebral body injection; cervicothoracic
    22856Total disc arthroplasty anterior approach, single interspace cervical
    23700Manipulation under anesthesia, shoulder joint (note: 'Add effective 01/01/2024')
    CPT procedure groups requiring prior authCPTCovered
    23450-23466Shoulder capsulorrhaphy and related shoulder procedures (various CPT codes listed in this range)
    27130-27138Total hip arthroplasty and revisions
    27403-27447Knee arthrotomy/arthroplasty/ligament procedures
    29805-29916Arthroscopy procedures for shoulder, hip, knee (many codes listed)
    62280-62320Spine injection/neurolytic and injection procedures
    Selected CPT codes requiring prior authorizationCPTCovered
    29887Drilling For Intact Osteochondritis Dissecans Lesion With Internal Fixation
    29916Arthroscopy Hip With Labral Repair
    62280Injection/Infusion Of Neurolytic Substance; Subarachnoid
    62320Interlaminar epidural/subarachnoid injection without imaging guidance
    63001Laminectomy with exploration/decompression; cervical (<=2 segments)
    Minimum genes specified
    Minimum genes per panelPanels specify minimum gene counts ranging from 5 to 100+ depending on indication
    Example: cardiomyopathy panelsSome cardiomyopathy panels must include sequencing of at least 5 genes (e.g., DSG2, MYBPC3, MYH7, PKP2, TTN)
    Example: mitochondrial panels

    How Providers Request Authorizations and Operational Notes

    Prior Authorization

    How to request prior authorization

    For requests handled by Blue Cross Blue Shield of Texas, initiate authorization via: Availity Authorization & Referrals; Blue Approvr; or by calling the prior authorization number on the member's ID card. For services handled by Carelon Medical Benefits Management call 1-866-455-8415.

    • Availity Authorization & Referrals
    • Blue Approvr
    • Call the prior authorization number on the member's ID card
    • For Carelon-managed services call 1-866-455-8415
    Prior Authorization

    Prior authorization required for listed imaging codes

    Numerous advanced imaging and related CPT/HCPCS codes in the list require prior authorization; many of these entries identify Carelon as the reviewer/vendor responsible for authorization.

    • Examples include CT/MR angiography, PET/SPECT and other advanced imaging CPTs routed to Carelon

    Terms and Vendor Definitions

    Member ID indicator
    ID card indicator for fully insured members'TDI' will be indicated on the member's ID card for Fully Insured Members
    Effective date of listThe prior-authorization code list is effective 1/1/2024 (document header)
    Note on coveragePresence on this list does not necessarily indicate coverage; refer to benefit booklet or customer service
    Administrative reviewer / vendor
    Named administrative reviewer/vendorCarelon is identified as the reviewer/vendor responsible for prior authorization processing for many listed codes
    Carelon routing evidenceMultiple advanced imaging and molecular genetic entries show '3 = Carelon' in the code list

    Document Status and Revision Notes

    2024-01-01effective_date

    Document lists prior authorization requirements effective 01/01/2024 (codes added/flagged with 'Add effective 01/01/2024', and lists apply as of this date).

    2024-04-01effective_date

    Several codes (including multiple molecular/genetic and infusion-site/drug codes) were added with 'Add effective 04/01/2024' annotations indicating they require prior authorization from this date.

    2024-07-01effective_date
    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    Policy2024 Commercial Prior Authorization Codes for ASO (partial list)
    Policy CodePolicy N/A
    Change TypeNo material changes in this revision
    Effective DateJan 1, 2024
    Next Review DateN/A
    Key ActionObtain prior authorization via Availity Authorization & Referrals, Blue Approvr, the member ID card number, or Carelon (1-866-455-8415) for codes managed by Carelon.
    SourceLink
    On This Page
    Prior Authorization Coverage CriteriaRepresentative Codes and Coding NotesHow Providers Request Authorizations and Operational NotesTerms and Vendor DefinitionsDocument Status and Revision Notes
    Nuclear-encoded mitochondrial gene panels must include analysis of at least 100 genes (examples listed)
    Example: inherited bone marrow failure panelsInherited bone marrow failure syndrome panels must include sequencing of at least 30 genes
    Specialty / service lines
    Primary specialties associatedAdvanced Imaging/Radiology and Cardiology are primary service lines associated with many listed procedure codes
    Examples of modality mappingEntries list PET/SPECT/CT, MRI, CT angiography and echocardiography under Advanced Imaging/Radiology; Cardiology mapping is shown for myocardial imaging codes
    ASO routing noteCertain echocardiography/Doppler codes are annotated to be added to the ASO List effective 1/1/2024
    Effective-date additions
    Add effective 01/01/2024 — multiple CPTsSeveral CPT codes in the list are annotated 'Add effective 01/01/2024', indicating they were added to the prior-authorization list as of Jan 1, 2024
    Example: CPT 23700CPT 23700 (manipulation under anesthesia, shoulder) is shown with 'Add effective 01/01/2024'
    Arthroscopy and hip codesMultiple arthroscopy and hip arthroscopy CPTs (e.g., 29805–29916 range) include 'Add effective 01/01/2024' notes
    Spine and related procedure addsNumerous spine and musculoskeletal CPTs in the excerpt include the same effective-date annotations
  1. Presence on the list indicates prior authorization is required; consult the listed reviewer
  2. Prior Authorization

    Prior authorization routing and ASO list flags

    Specific echocardiography CPTs (e.g., 93303, 93304, 93351, 93352) are on the prior authorization list and are routed to Carelon; several are annotated 'Add to ASO List effective 1/1/2024'.

    • 93303 and 93304 routed to Carelon and flagged 'Add to ASO List effective 1/1/2024' (transthoracic echocardiography for congenital anomalies)
    • 93351 and 93352 routed to Carelon and flagged 'Add to ASO List effective 1/1/2024' (contrast/stress echocardiography)
    Prior Authorization

    General prior authorization requirement for listed imaging/cardiology codes

    A broad set of advanced imaging, cardiology CPTs and temporary T-codes (PET, SPECT, CT, MRI quantitative/T-codes) require prior authorization; many of these entries designate Carelon as the review vendor.

    • Includes PET/SPECT myocardial perfusion (e.g., 78430–78433, 78451), various nuclear medicine/CT/T-codes and advanced MRI codes
    • Carelon is identified as the reviewer/vendor for many listed advanced imaging and cardiology codes
    Prior Authorization

    Prior authorization required — selected advanced imaging and cardiology codes

    The document enumerates specific advanced imaging and cardiology procedure and HCPCS/T-codes (examples include 93351, 93352, 0042T, 0633T, 0648T) that require prior authorization, with Carelon noted as the reviewer for many entries.

    • 93351, 93352, 0042T, 0633T, 0634T, 0635T, 0636T, 0637T, 0638T, 0648T, 0649T, A9602, A9800, C8900, C8901, C8902, C8903
    Prior Authorization

    Prior authorization required — ENT/cochlear device codes

    ENT procedures and cochlear implant/device supply codes (including L8614–L8629, L8690–L8693 and multiple CPTs) require prior authorization and are routed to Blue Cross Blue Shield of Texas (BCBSTX) for authorization.

    • Examples include implant and supply HCPCS codes L8615–L8619, L8621–L8624, L8627–L8629
    • BCBSTX is listed as the authorization routing for these ENT/cochlear device items
    Prior Authorization

    Prior authorization required — gastroenterology and molecular genetic testing codes

    Gastroenterology procedures and numerous molecular genetic testing CPTs are listed as requiring prior authorization; many molecular genetic entries identify Carelon as the reviewer/vendor.

    • Gastroenterology examples (e.g., 43648, 43881) are routed to BCBSTX or Carelon as noted
    • Molecular genetic CPTs in this section (81120–81183 range and beyond) are routed to Carelon
    Prior Authorization

    Prior authorization required for listed molecular genetic tests

    A long list of molecular genetic CPT procedure codes (e.g., 81174–81287 and many others) require prior authorization; Carelon is identified as the managing review organization for most codes in this segment.

    • Includes gene-specific tests (BRCA, CFTR, HTT, FMR1, JAK2, etc.)
    • Carelon is shown as the reviewer for the majority of these molecular genetic entries
    Prior Authorization

    Prior authorization requirement and vendor (specific CPTs 81360–81364)

    Molecular genetic lab testing CPT codes in the 81360–81364 range require prior authorization and are managed by Carelon.

    • 81360–81364 listed with Carelon as the authorization manager
    Prior Authorization

    Specific gene tests requiring prior authorization (81360–81364)

    Specific molecular genetic CPTs 81360–81364 require prior authorization and are managed by Carelon as the authorization reviewer.

    • 81360, 81361, 81362, 81363, 81364 — Carelon listed as reviewer
    Prior Authorization

    Molecular pathology and genomic sequencing prior authorization

    Molecular pathology and genomic sequencing CPT codes in the 81400–81427 range require prior authorization; many entries specify procedure levels, example indications and list Carelon as the review entity.

    • Includes molecular pathology procedure levels (81401–81410) and exome/genome sequencing codes (81415–81427)
    • Carelon is identified as the reviewer for many of these codes
    Prior Authorization

    Prior authorization required for listed molecular genetic tests (panel notes)

    A broad set of molecular genetic/genomic testing codes (numerous CPT/HCPCS/U codes listed) require prior authorization; many entries indicate Carelon as the authorization manager.

    • Examples include exome/genome re-evaluation codes and panel-specific entries that note Carelon as reviewer
    • Panel composition and minimum gene counts are specified for several codes
    Prior Authorization

    Prior authorization required for listed molecular/genetic tests

    Numerous molecular genetic and related procedure codes—including many CPT and U-codes—are listed as requiring prior authorization and are associated with Carelon as the authorization manager.

    • Examples include 81595, OO01U, 0048U and other molecular/genetic procedure codes
    • Carelon is shown as the reviewer for many entries
    Prior Authorization

    Prior authorization requirement (vendor) for U-codes

    Prior authorization is required for numerous U-code molecular genetic lab tests; Carelon is identified as the designated authorization vendor for these U-code entries.

    • Selected U-codes (e.g., 0131U–0135U series) list Carelon as the reviewer
    • Panel tests often include 'List Separately In Addition To Code For Primary Procedure' instructions
    Prior Authorization

    Prior authorization required — molecular genetic testing (selected U-codes)

    Selected molecular genetic/genomic U-codes (for example 0274U, 0276U, 0277U, 0278U, 0285U, 0286U) require prior authorization and identify Carelon as the reviewer for these tests.

    • 0274U, 0276U, 0277U, 0278U, 0285U, 0286U, 0287U, 0288U, 0289U, 0290U, 0291U, 0292U, 0293U, 0294U, 0296U
    Prior Authorization

    Newly effective codes requiring prior authorization (effective 01/01/2024)

    Several oncology MRD and large genomic panel codes (e.g., 0368U, 0378U, 0379U, 0380U) are flagged with 'Add effective 01/01/2024', indicating they were newly added to the prior authorization list effective that date.

    • 0368U, 0378U, 0379U, 0380U — Carelon listed and annotated 'Add effective 01/01/2024' for many
    Note

    Prior authorization vendor assignment — Carelon

    Carelon is listed repeatedly as the authorization entity for many of the molecular genetic and other listed procedures (examples include codes in the 0368U–0380U and 0405U ranges).

    • Carelon is denoted as the reviewer/authorization manager for multiple molecular genetic codes
    Documentation Required

    Upcoming additions with effective dates

    Certain molecular genetic codes include future 'Add effective' annotations (for example 0405U Add Effective 07/01/2024; 0428U Add effective 04/01/2024), indicating those codes will require prior authorization beginning on the noted effective dates.

    • 0405U, 0409U, 0410U annotated 'Add Effective 07/01/2024'
    • 0428U annotated 'Add effective 04/01/2024'
    Prior Authorization

    Prior authorization required — musculoskeletal/spine surgery categories

    Musculoskeletal and spine surgery procedure categories (including numerous CPTs for arthroscopy, arthroplasty, spine procedures and injections) require prior authorization; Carelon is listed as the reviewer/administrator for these entries.

    • Includes spine CPTs (e.g., 22208–22510, 22800–22865) and musculoskeletal procedures routed to Carelon
    • Some codes include 'Add effective 01/01/2024' annotations
    Prior Authorization

    Prior authorization required — listed musculoskeletal procedures

    Specific procedures listed in the musculoskeletal/spine sections require prior authorization and are routed to Carelon for authorization review.

    • Provider must obtain prior authorization through Carelon for the listed musculoskeletal CPTs
    Documentation Required

    Effective date notes — codes added 01/01/2024

    Many CPT codes in the list are annotated 'Add effective 01/01/2024', indicating those CPTs were added to the prior authorization requirement list effective January 1, 2024.

    • Examples: 23700 and multiple arthroscopy/arthroplasty/orthopedic codes include the 'Add effective 01/01/2024' note
    Prior Authorization

    Arthroscopy and related procedures prior authorization

    Hip and other arthroscopy procedure codes (e.g., 29887–29916 series) require prior authorization via Carelon; several entries are annotated 'Add effective 01/01/2024'.

    • 29887, 29888, 29889, 29892, 29914, 29915, 29916 — Carelon listed as reviewer; many flagged with Add effective 01/01/2024
    Prior Authorization

    Spine injection procedures prior authorization

    Spine injection procedures and neurolytic substance injections (CPTs such as 62280–62292, 62320–62327) require prior authorization and are routed to Carelon.

    • 62280–62292 (neurolytic/injection procedures) and 62320–62327 (epidural/diagnostic/therapeutic injections) require prior authorization through Carelon
    Prior Authorization

    Implantation and decompression procedures prior authorization

    Implantation, revision or replacement procedures for intrathecal/epidural catheters and pumps (e.g., 62350–62362) and decompression/laminectomy codes require prior authorization through Carelon.

    • 62350–62362 (implantation/revision of intrathecal/epidural catheters and pumps) routed to Carelon
    • Decompression/laminectomy related CPTs require prior authorization
    Prior Authorization

    Spinal surgery prior authorization

    An extensive set of spinal surgery CPTs (laminectomy, laminotomy, corpectomy, discectomy, vertebral resection and related codes) require prior authorization; Carelon is listed as the authorization reviewer for these procedures.

    • Examples include 63001, 63003, 63005, 63012, 63015–63017, 63020, 63030–63037, 63040–63057, 63075–63091, 63101–63103, 63200–63285
    • Provider must obtain prior authorization via Carelon for these spinal surgery CPTs
    Provider contact for Carelon-managed servicesAuthorization requests for services handled by Carelon should be initiated via the vendor as indicated in the policy (Carelon phone referenced elsewhere)
    ASO List
    ASO List flagSpecific echocardiography codes and other entries are marked 'Add to ASO List effective 1/1/2024' in the code listings
    Examples citedMultiple transthoracic and transesophageal echocardiography CPTs include the ASO List annotation (e.g., 93303–93317, 93351–93352)
    ImplicationASO List designation identifies administration routing and may affect prior-authorization handling for ASO accounts
    Carelon — vendor / processor
    Carelon as designated vendor/processorCarelon is repeatedly shown as the designated vendor/processor for prior authorization review for many listed codes (e.g., PET, nuclear cardiology, advanced imaging entries)
    Carelon mapping examplesEntries for codes such as 78430, 78811–78816, and numerous molecular genetic codes include '3 = Carelon'
    Carelon handles complex imaging and genetic reviewsCarelon is listed across imaging, cardiology and molecular genetic sections as the review organization
    Carelon — prior authorization vendor
    Carelon referenced as prior authorization vendorMany imaging and cardiology CPT/HCPCS/T-code entries include '3 = Carelon', indicating Carelon is the prior authorization vendor
    ExamplesEchocardiography and CT perfusion T-codes (e.g., 0042T, 0633T) and PET/CT codes list Carelon as reviewer
    Provider action implicationProviders should route prior-authorization requests for these codes to Carelon per the listing
    BCBSTX routing
    BCBSTX internal reviewer routingCertain ENT and cochlear implant device procedure and supply codes are routed to BCBSTX (Blue Cross Blue Shield of Texas) for prior authorization
    ExamplesDevice supply codes (L8615–L8623, L8690, L8691) show '3 = BCBSTX' in the listing
    DistinctionBCBSTX routing indicates internal handling rather than external vendor routing (Carelon)
    Managed review organization — genetic tests
    Carelon assigned as managed review organization for genetic testsCarelon is identified as the managed review organization assigned to process prior authorization for many listed genetic tests (entries show '3 = Carelon')
    Genetic test examplesNumerous gene-specific CPTs (e.g., 81174–81180, 81208–81210) indicate Carelon as reviewer
    Implication for providersAuthorization requests for listed molecular genetic tests should be submitted to Carelon per the policy mappings
    Category: Molecular Genetic Lab Testing
    Category: Molecular Genetic Lab TestingThe document repeatedly categorizes many CPT/HCPCS entries under 'Molecular Genetic Lab Testing' for gene-specific analyses, sequencing and variant testing
    Included proceduresEntries include gene-specific single-gene tests, multi-gene panels, exome/genome sequencing, and U-code genomic assays
    Billing noteSome panel items include 'List Separately In Addition To Code For Primary Procedure' instructions where applicable
    Authorization vendor — molecular genetic tests
    Authorization vendor for molecular genetic testsCarelon is identified as the authorization vendor for multiple molecular genetic CPT and U-code entries in the list
    ExamplesSpecific gene and molecular pathology codes (e.g., 81360–81364, 81400–81427) show Carelon as the reviewer in the listings
    Provider implicationPrior authorization for listed molecular genetic tests should be obtained via Carelon as indicated
    Molecular Pathology Procedure Level
    Molecular pathology procedure levelMolecular pathology procedure levels (e.g., CPT 81401–81410) indicate complexity/number of targets or exons analyzed (examples Level 2–9 are described)
    Level examplesLevel 2: 2–10 targets or single methylated/somatic variant; Level 9: analysis of >50 exons in a single gene
    Use in prior-auth mappingProcedure level is specified per CPT entry and mapped to Carelon for authorization handling
    Exome / Genome re-evaluation
    Exome/genome re-evaluationCodes for exome/genome re-evaluation (e.g., 81418, 81419, 81422, 81425–81427) describe re-analysis of previously obtained exome/genome sequence data due to updated knowledge or new evaluation
    Examples of re-evaluation codes81418 and 81419 explicitly reference re-evaluation of previously obtained exome sequence data
    Vendor mappingThese re-evaluation codes are listed with Carelon as the reviewer in the code list
    Authorization manager / vendor
    Authorization manager/vendor referencedCarelon is cited repeatedly as the authorization manager/vendor for listed molecular genetic and related procedures
    Evidence locationMultiple code entries across molecular genetic sections show '3 = Carelon' or list Carelon in the reviewer column
    Provider actionSubmit prior-authorization requests to Carelon where the code mapping indicates Carelon as reviewer
    Effective date notes (04/01/2024)
    Items effective 04/01/2024Some molecular genetic procedure entries are annotated 'Add effective 04/01/2024' (e.g., CPTs 81457–81459, 81463-related entries)
    Examples81457, 81458 and 81459 list 'Add effective 04/01/2024' in the code listing
    ImplicationThese codes will require prior authorization starting on the specified April 1, 2024 effective date
    Molecular Genetic Lab Testing (term use)
    Molecular Genetic Lab Testing — term useThe list repeatedly uses 'Molecular Genetic Lab Testing' to categorize panels, exome/genome assays, microarray and gene-expression profiling procedures
    Examples of procedures under this termIncludes gene-specific CPTs, multi-gene panels, exome/genome sequencing (81415–81427), and U-code genomic assays (e.g., 0211U, 0244U)
    Vendor mappingMost entries under this category show Carelon as the authorization manager
    Carelon — utilization / prior auth manager
    Carelon — utilization/prior authorization managerCarelon is referenced repeatedly as the utilization/prior authorization manager for many listed procedure codes, including molecular genetic tests and advanced imaging
    Multiple referencesCarelon is listed in numerous chunk entries across imaging, molecular genetics and musculoskeletal sections (e.g., chunks 36, 72, 126, 216)
    Provider implicationProviders should follow the vendor routing indicated (Carelon) when obtaining prior authorization for listed codes
    Designated prior authorization vendor
    Designated prior authorization vendor for molecular genetic testsCarelon is designated as the prior-authorization vendor for the listed molecular genetic U-code tests
    U-code examplesSelected U-codes (e.g., 0131U, 0132U, 0211U, 0244U) show Carelon in the reviewer column
    Action for providersSubmit authorization requests for these U-code molecular tests to Carelon per the mapping
    Billing instruction — list separately
    Billing instruction: list separately when requiredSome panel/targeted tests include the instruction 'List Separately In Addition To Code For Primary Procedure' (document shows this billing note for relevant entries)
    ExampleCYP2D6 targeted analyses (e.g., 0072U–0076U) include 'List Separately In Addition To Code For Primary Procedure' in their descriptions
    Provider implicationWhen indicated, bill the panel/test separately in addition to the primary procedure code as shown in the code listing
    MRD — minimal residual disease
    MRD (Minimal Residual Disease) definitionMRD assays are personalized to each patient based on prior tumor and germline sequencing and reported as presence or absence of MRD with disease-burden correlation when appropriate (e.g., CPT 0341U)
    Example codeCPT/U-code 0341U describes MRD analysis from plasma personalized to each patient
    Vendor mappingMRD assay entries list Carelon as the reviewer in the code list
    Fetal aneuploidy testing
    Fetal aneuploidy testing definitionFetal aneuploidy testing is DNA sequence analysis of selected regions using maternal plasma reported as a risk score for trisomies 13, 18 and 21 (and sex when performed)
    Example codesCPT/U-codes 0329U, 0331U, 0332U, 0333U are described as fetal aneuploidy assays using maternal plasma algorithms
    Vendor mappingThese fetal aneuploidy entries list Carelon as the reviewer in the listing
    Molecular Genetic Lab Testing — definition
    Molecular Genetic Lab Testing — definitionLaboratory procedures involving genomic sequence analysis, targeted panels, gene variant analysis, and related molecular diagnostics as described in the code entries
    Included assay typesIncludes single-gene analyses, multi-gene panels, exome/genome sequencing, copy-number and RNA analyses, and gene-expression profiling
    Examples in listCodes such as 81400–81427, numerous U-codes and HCPCS entries are categorized under this term
    Carelon — named prior auth vendor
    Carelon — named prior authorization vendor/administratorCarelon is named as the prior authorization vendor/administrator for many listed procedures across sections (molecular genetics, imaging, musculoskeletal) in the code listings
    Examples across sectionsCarelon mapping appears for codes in the molecular genetic (e.g., 0211U), imaging (e.g., 78430) and spine/surgery sections (e.g., 22208)
    Provider actionProviders should submit prior-authorization requests to Carelon when the code mapping indicates Carelon as the reviewer
    Carelon — reviewer / authorization manager
    Carelon — reviewer/authorization managerCarelon is repeatedly listed as the reviewer/authorization manager for prior-authorization processing of listed procedure codes
    Musculoskeletal examplesMany spine and joint CPTs (e.g., 22208, 22510, 23700) in the musculoskeletal section show Carelon as reviewer
    ImplicationCarelon handles authorization review and routing for a broad set of clinical areas in this list
    Effective date note — example
    Effective date note (CPT 23700)CPT 23700 is explicitly annotated 'Add effective 01/01/2024' in the excerpt
    ContextThis explicit effective date appears in the musculoskeletal code listing and signals when prior-authorization requirement began for that code
    Provider implicationObtain prior authorization for CPT 23700 starting on or after 01/01/2024 per the listing
    Carelon — prior authorization administrator
    Carelon — prior authorization administratorCarelon is referenced as the prior-authorization administrator/vendor for processing authorizations for many listed procedures in the document
    EvidenceMultiple code entries across the molecular genetic and procedural sections include '3 = Carelon' or list Carelon in the reviewer column
    ActionSubmit prior-authorization requests to Carelon when indicated for the code
    Add effective 01/01/2024
    Add effective 01/01/2024 annotation'Add effective 01/01/2024' is used in multiple code entries to indicate the code was added to the prior-authorization list effective January 1, 2024
    ScopeThis annotation appears across musculoskeletal, arthroscopy and other procedure listings (e.g., 29805–29916, 23700)
    Provider implicationCodes with this annotation require prior authorization beginning on the indicated effective date
    Carelon — repeated reference
    Carelon referenced againCarelon is repeatedly cited across sections as the prior-authorization vendor for listed procedures (musculoskeletal and genetic tests among others)
    ExamplesCarelon mapping is present for many CPTs including arthroscopy, spine surgery and molecular genetic codes
    ImplicationProviders should follow Carelon routing for authorization where mapped
    Prior authorization requirement — summary
    Prior authorization required for listed CPTsPrior authorization is required for the listed CPT procedure codes; some codes are noted as added effective 01/01/2024
    Examples of affected categoriesIncludes advanced imaging, molecular genetic lab testing, arthroscopy, spine surgery and other specialty procedures listed
    Provider instructionObtain prior authorization through the indicated reviewer (commonly Carelon) before performing the listed procedures

    Additional codes (notably specialty pharmacy and certain molecular/genetic codes) annotated 'Add Effective 07/01/2024' were scheduled to require prior authorization as of this date.

    2024-10-01effective_date

    Multiple U-codes and other molecular/genetic codes show 'Add Effective 10/01/2024' or retire effective 10/01/2024 indicating further updates to prior authorization routing and requirements effective this date.

    2024-07-2024update_notice

    Header notes the list is 'Effective 1/1/2024 (Updated July 2024)', indicating a document update in July 2024 that revised the effective list content.

    2024-06-25update_notice

    Change log entry indicating updates effective 10/01/2024 were posted on 06/25/2024 (Additions/removals of genetic testing and oncology code reviews).

    2024-03-25update_notice

    Change log entry for 03/25/2024 describing additions effective 07/01/2024 including specialty pharmacy and genetic testing codes to be reviewed by Carelon.

    2023-12-22update_notice

    Change log entry noting additions effective 04/01/2024 (gene therapy codes) posted 12/22/2023.

    2023-09-18update_notice

    Change log entry noting additions effective 01/01/2024: specialty pharmacy medications and additions to genetic testing, medical oncology, and musculoskeletal categories (posted 09/18/2023).

    2024-07-01document_updateLatest

    Replacement/addition of certain oncology and specialty pharmacy code assignments noted in updates (e.g., J3055 replacing C9163 on 07/01/2024).